2027 BSF Grant Program
The 2027 BSF Grant Program funds innovative research on Barth syndrome, supporting basic, translational, and clinical studies to advance understanding and therapies for this rare disorder.
Funder: Barth Syndrome Foundation
Due Dates: October 30, 2026 (Full Applications due)
Funding Amounts: Up to $100,000 total for 1–3 years; indirect costs capped at 10% of direct costs.
Summary: Seed funding for independent investigators to advance basic, translational, or clinical research on Barth syndrome.
Key Information: No geographic restrictions; pre/postdocs not eligible—faculty appointment required.
Description
The Barth Syndrome Foundation (BSF) Grant Program offers seed funding to support innovative research projects that address fundamental, translational, and clinical challenges related to Barth syndrome. The program aims to catalyze impactful research by providing preliminary data necessary for securing larger, follow-on grants from major institutions such as the NIH. Applications undergo a competitive peer review by BSF’s Scientific and Medical Advisory Board and external experts. Both early-career and established independent investigators are encouraged to apply, provided their research aligns with BSF’s mission to advance the understanding and treatment of Barth syndrome.
